DOI: http://dx.doi.org/10.18203/issn.2455-4529.IntJResDermatol20183154

Evaluation of thyroid function status in patients with alopecia areata

Ehimen P. Odum, Collins Amadi, Bolaji I. Otike-Odibi

Abstract


Background: Epidemiologic reports suggest a high prevalence of thyroid function abnormalities among patients with alopecia areata. Hence, this study was designed to investigate this hypothesis among indigenous Nigeria patients with alopecia areata.

Methods: The study was a retrospective analysis of records of thyroid function investigations of patients with alopecia areata who had presented to the Department of Chemical Pathology and Metabolic Medicine of the University of Port Harcourt Teaching Hospital (UPTH), Nigeria over a 10-year period (1st January 2007 and 31st December 2016). Records of patients’ age, sex, thyroid stimulating hormone (TSH), total thyroxine (T4), and total triiodothyronine (T3) were acquired from laboratory records and analyzed using SPSS version 15. A p<0.05 was applied as being significant.

Results: One hundred and thirteen (113) records of patients with alopecia areata were reviewed, among them 55 (48.7%) males and 58 (51.3%) females with no sex difference (p=0.778). The mean age of study cohorts was 29.42±10.27 (range 16–63) with the majority (61.9%) between the age group 20 to 40 years. No difference in the mean age, TSH, and T3 levels were observed between the males and females. Thyroid function abnormalities were observed in 27.3% of study cohorts and the most prevalent abnormality was hypothyroidism (16.8% subclinical and 4.4% primary) with a female preponderance.

Conclusions: The study suggests an association of alopecia areata with thyroid function abnormalities. Patients with alopecia areata should be screened for thyroid function abnormalities irrespective of clinical status.


Keywords


Alopecia areata, Thyroid functional abnormalities, Hypothyroidism

Full Text:

PDF

References


Gilhar A, Etzioni A, Paus R. Alopecia areata. N Engl J Med. 2012;366:1515–25.

Perera E, Yip L, Sinclair R. Alopecia areata. Curr Probl Dermatol. 2015;47:67–75.

Frick ACV, Miteva M. Epidemiology and burden of alopecia areata: a systemic review. Clin Cosmet Investig Dermatol. 2015;8:378–403.

Wasserman D, Guzman-Sanchez DA, Scott K, McMicheal A. Alopecia review. Int J Dermatol. 2007;46:121-32.

Sani H, Ogunbiyi AO, Okoro OE. Prevalence and pattern of alopecia in secondary and tertiary institutions in Ibadan. Sub-sahara Afr J Med. 2016;3:148–52.

Emeka OO, Hadiza S. Pattern of skin diseases at the dermatology clinic of Jos University Teaching Hospital, Jos, Plateau state, Nigeria. Jos J Med. 2014;8:15–21.

Mitchel AJ, Krull EA. Alopecia areata: Pathogenesis and treatment. J Am Acad Dermatol. 1984;11:763–75.

Strazzula LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia areata: Disease characteristics, clinical evaluation, and new perspective on pathogenesis. J Am Acad Dermatol. 2018;78:1-12.

Stankler L. Synchronous alopecia areata is two siblings: a possible viral etiology. Lancet. 2002;29:85–90.

McElwee KJ, Gilhar A, Tobin DJ, Ramot Y, Sundberg JP, Nakamura M, et al. What causes alopecia areata? Exp Dermatol. 2013;22:609–26.

Islam N, Leung PS, Huntley AC, Gershwin ME. The autoimmune basis of alopecia areata: a comprehensive review. Autoimmun Rev. 2015;14:81–9.

Hordinsky MK. Overview of Alopecia areata. J Investig Dermatol Symp Proc. 2013;16:13–5.

Tobin DJ, Orentreich N, Fenton DA, Bystryn JC. Antibodies to hair follicles in alopecia areata. J Investig Dermatol. 1994;102:721–4.

Tobin JD. Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc. 2003;8:176–81.

Amirnia M, Mahmoudi S, Karkon-Shayan F, Alikhah H, Piri R, Naghavi-Behzad M, et al. Comparative study of intralesional steroid injection and cryotherapy in alopecia areata. Niger Med J. 2015;56:249–52.

Hordinsky M, Ericson M. Autoimmunity: Alopecia areata. J Investig Dermatol Symp Proc. 2004;9:73–8.

(Kasumagic-Halilovic E. Thyroid autoimmunity in patients with alopecia areata. Acta Dermatoveneral Croat. 2008;16:123–5.

Seyrafi H, Akhiani M, Abbassi H, Mirpour S, Gholamrezanehad A. Evaluation of the profile of alopecia and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol. 2005;5:11.

Bakry OA, Basha MA, Shafiee MKE, Shehata WA. Thyroid disorders with alopecia areata in Egyptian patients. Indian J Dermatol. 2014;59:49–55.

Puavilai S, Puavilai G, Charuvichitratana S, Sakuntabhai A, Sriprachya-aunt S. Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol. 1993;33:632–3.

Thomas EA, Kadyan RS. Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol. 2008;53:70 -4.

Lyakhovitsky A, Shemer A, Amichai B. Increased prevalence of thyroid disorders in patients with new onset alopecia areata. Aust J Dermatol. 2015;56:103-6.

McDonagh AJ, Taxi-Ahnini R. Epidemiology and genetics of alopecia areata. Clin Exp Dermatol; 2002;27:405–9.

Muller SA, Winkelmann RK. Alopecia areata: an evaluation of 736 patients. Arch Dermatol. 1963;88:290–7.

Oztekin A, Metin A, Kirbas SC, Oztekin C. Frequency of alopecia areata in patients with autoimmune diseases. Apollo Med. 2017;14:165–70.